Bronchial asthma is a common inflammatory disease caused by the interaction of genetic and environmental factors 1,2 . Through a genome-wide association study and a replication study consisting of a total of 7,171 individuals with adult asthma (cases) and 27,912 controls in the Japanese population, we identified five loci associated with susceptibility to adult asthma. In addition to the major histocompatibility complex and TSLP-WDR36 loci previously reported, we identified three additional loci: a USP38-GAB1 locus on chromosome 4q31 (combined P = 1.87 × 10 −12 ), a locus on chromosome 10p14 (P = 1.79 × 10 −15 ) and a gene-rich region on chromosome 12q13 (P = 2.33 × 10 −13 ). We observed the most significant association with adult asthma at rs404860 in the major histocompatiblity complex region (P = 4.07 × 10 −23 ), which is close to rs2070600, a SNP previously reported for association with FEV 1 /FVC in genome-wide association studies for lung function. Our findings offer a better understanding of the genetic contribution to asthma susceptibility.
l e t t e r s
Bronchial asthma is a common inflammatory disease caused by the interaction of genetic and environmental factors 1,2 . Through a genome-wide association study and a replication study consisting of a total of 7,171 individuals with adult asthma (cases) and 27,912 controls in the Japanese population, we identified five loci associated with susceptibility to adult asthma. In addition to the major histocompatibility complex and TSLP-WDR36 loci previously reported, we identified three additional loci: a USP38-GAB1 locus on chromosome 4q31 (combined P = 1.87 × 10 −12 ), a locus on chromosome 10p14 (P = 1.79 × 10 −15 ) and a gene-rich region on chromosome 12q13 (P = 2.33 × 10 −13 ). We observed the most significant association with adult asthma at rs404860 in the major histocompatiblity complex region (P = 4.07 × 10 −23 ), which is close to rs2070600, a SNP previously reported for association with FEV 1 /FVC in genome-wide association studies for lung function. Our findings offer a better understanding of the genetic contribution to asthma susceptibility.
The precise mechanisms underlying the development and progression of bronchial asthma have not been fully elucidated. Genomewide association studies (GWAS) have contributed to identification of common genetic variants related to common diseases, including asthma 3 . GWAS of asthma in European and African-ancestry populations [4] [5] [6] [7] [8] have been conducted, and a recent large-scale, consortiumbased GWAS among European populations reported ten loci strongly associated with asthma 9 . To provide further information for a better understanding of the genetic basis of asthma, GWAS using different ethnic populations are also needed.
Because there have been few large-scale analyses of asthma in Asian populations, we conducted a GWAS with 1,532 cases and 3,304 controls in the Japanese population, using Illumina HumanHap 550v3 and 610-Quad BeadChips (Supplementary Table 1) . After principal component analysis and quality-control filtering, we excluded one outlier before the association analysis and subjected a total of 458,847 SNP loci to statistical analysis; we then generated a quantile-quantile plot using the results of a Cochran-Armitage test (Supplementary Fig. 1a,b) . The genomic inflation factor (λ GC ) was 1.07, and we calculated the λ 1,000 adjusted by sample size to be 1.03, indicating a low possibility of false-positive associations resulting from population stratification. We observed the strongest association (at rs8192565) in the major histocompatibility complex (MHC) class III region on chromosome 6p21 (Fig. 1) , and two variants in the NOTCH4 and C6orf10 loci reached the genome-wide significant threshold (P < 5 × 10 −8 ; Supplementary Fig. 1c) .
We validated the association of previously reported loci for bronchial asthma in GWAS. A recent large-scale, consortium-based GWAS identified ten loci for asthma with genome-wide significance 9 . Our GWAS replicated three SNPs reported in the previous study: rs1063355 on chromosome 6p21 (P = 0.0010), rs11071559 on chromosome 15q22 (P = 0.0036) and rs744910 on chromosome 15q22 (P = 0.0095) (Supplementary Table 2a,b) . We also checked the associations of genes reported by previous GWAS for asthma [5] [6] [7] 9 . The SNPs for which we observed replication of the association with P < 0.05 in our GWAS are shown in Supplementary Table 2c.
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VOLUME 43 | NUMBER 9 | SEPTEMBER 2011 Nature GeNetics l e t t e r s To investigate additional susceptibility loci for adult asthma, we conducted a replication study using an independent set of 5,639 cases and 24,608 controls. We genotyped the 102 SNPs that showed CochranArmitage trend P < 1 × 10 −4 in our GWAS after excluding 31 SNPs having r 2 > 0.9 with some of these 102 SNPs. In the replication study, 24 of the 102 SNPs replicated their significant associations with Bonferroni-corrected P < 4.9 × 10 −4 (calculated as 0.05/102) (Supplementary Table 3 ). When we combined the data from the GWAS and replication study using the Mantel-Haenszel method, all of the 24 SNPs in five genomic loci were significantly associated with adult asthma at genome-wide significant levels (P < 5 × 10 −8 ): chromosome 4q31 (rs7686660, combined P = 1.87 × 10 −12 , odds ratio (OR) = 1.16), 5q22 (rs1837253, P = 1.24 × 10 −16 , OR = 1.17), 6p21 (rs404860, P = 4.07 × 10 −23 , OR = 1.21), 10p14 (rs10508372, P = 1.79 × 10 −15 , OR = 1.16) and 12q13 (rs1701704, P = 2.33 × 10 −13 , OR = 1.19) ( Table 1) . A recent study using a candidate gene approach reported that the marker SNP rs1837253, which is located 5.7 kb upstream of the transcription initiation site of TSLP, was associated with asthma and airway hyper-responsiveness 10 . It was also reported that the HLA locus is associated with asthma and allergen sensitization 9, 11 .
Considering these previously reported results, our data identified three loci newly associated with adult asthma.
After we combined the data of the GWAS and the replication study (Supplementary Table 3 ), 18 of the 26 SNPs in the MHC region showed association beyond the genome-wide significance threshold of P < 5 × 10 −8 . We observed the strongest association in the MHC class III region ( Table 1 and Fig. 1) . A recent large-scale European GWAS reported an association of the HLA-DQ locus (rs9273349) with asthma, and cases with lateronset asthma seemed to be influenced more markedly by this locus than cases with childhood-onset asthma 9 . To examine the relationship between rs9273349 and rs8192565, we conducted a logistic regression analysis using the GWAS data. Because rs9273349 was not included in our GWAS data, we used rs1063355 as a proxy SNP (r 2 = 1 between rs1063355 and rs9273349 in the HapMap JPT and CEU populations) (Supplementary Table 2b ). The strong association of SNPs in the MHC class III locus remained after l e t t e r s adjustment for rs1063355 (Supplementary Fig. 2 ). This result indicated that the association observed in our study was independent of rs1063355 (and hence, rs9273349) in the HLA-DQ locus. Recent GWAS of natural variations in lung function have shown that a non-synonymous coding SNP in AGER (rs2070600) on chromosome 6p21 is associated with forced expiratory volume in one second (FEV 1 )/forced vital capacity (FVC) 12, 13 . Reduction of FEV 1 /FVC is a characteristic of obstructive lung diseases such as asthma 14 . rs2070600 showed relatively weak linkage disequilibrium (LD) with rs404860 in the Japanese population (r 2 = 0.115 and D′ = 0.805; Supplementary  Table 2b ) and did not show association with adult asthma in our study. However, rs404860 is located close to rs2070600, 32.9 kb downstream of the SNP (Fig. 1) . Asthma is a heterogenous disease with differences in severity and natural history, and lower pulmonary function is a feature of severe asthma. Thus, further genetic studies of asthma with detailed phenotypic characterization might help to clarify the relationship between genetic determinants of lung function and susceptibility to asthma.
To further investigate the gene(s) conferring susceptibility to adult asthma mapped to four loci (excluding the MHC region), we performed detailed mapping analyses using 1,532 cases and 3,304 controls from the GWAS (Fig. 2a-d) . We selected and genotyped tag SNPs (with minor allele frequency ≥0.05 and r 2 < 0.8) using the data from the HapMap phase 2 and 3 (release 27) Japanese individuals. The fine mapping analysis of the region on chromosome 5q22 using 13 tag SNPs showed that rs1837253 represented an associated LD block spanning 88 kb that included two genes, TSLP and WDR36 (Fig. 2a and Supplementary  Table 4a ). Respiratory viruses, multiple protease allergens and inflammatory cytokines can induce TSLP expression in airway epithelial cells, and TSLP plays a critical role in sensing environmental agents and mediating T helper type 2 (T H 2) cell responses following exposure 15 . Although further investigation is required to determine the function of the related variants in asthma, current annotation suggests that TSLP is the most plausible susceptibility gene in this locus.
Fine mapping analysis of the locus on chromosome 10p14 with 22 tag SNPs showed that rs10508372 is located within a 112-kb LD block that contains no reported genes ( Fig. 2b and Supplementary  Table 4b ). This region is a gene desert and is located 1 Mb downstream of GATA3, a master regulator of T H 2 cell differentiation 16 . As enhancers might influence the expression of the gene with Mb-long genomic distance 17 , it should be verified whether the variants within the associated region affect the activity of long range cis-regulatory elements controlling GATA3 expression.
The fourth locus is located in a gene-rich region on chromosome 12q13. Fine mapping analysis using 12 additional tag SNPs indicated that rs1701704 is present within a 201-kb LD block including 13 genes ( Fig. 2c and Supplementary Table 4c) . Recent association studies have shown that rs1701704 at this locus is associated with type I diabetes 18 and alopecia areata 19 . rs1701704 is located 2 kb upstream from IKZF4 (also known as EOS), which was shown to be involved in differentiation of regulatory T cells as a coregulator of FOXP3-directed gene silencing 20 . Regulatory T cells maintain pulmonary homeostasis and prevent harmful immune responses to innocuous inhaled antigens 21 . We finely mapped the fifth locus on chromosome 4q31 using 11 tag SNPs. The 497-kb susceptibility LD block region including rs1397527 contained USP38-GAB1 (Fig. 2d and Supplementary Table 4d) . USP38 encodes ubiquitin-specific peptidase 38, whose function is unclear. GAB1 is a scaffolding adopter protein that plays an important role in the signaling pathway activated by cytokine receptors for IL-3, IL-6, interferon α and γ, and B-cell and T-cell receptors 22 .
To examine the association of these variants with adult asthma in populations of different ancestries, we conducted an association study in 499 non-Hispanic individuals of European ancestry with mild to severe asthma from three adult asthma populations and 639 controls obtained from Illumina's iControl database. We found that rs1837253 on 5q22 showed a significant association with adult asthma (P = 0.023) (Supplementary Table 5 ). Hence, we conclude that the locus containing TSLP may be a common susceptible region for asthma across various ethnic groups.
In conclusion, we identified five loci that confer susceptibility to adult asthma in the Japanese population at genome-wide significant levels. The three new loci identified in our GWAS were not observed in a previous study with a large meta-analysis in which 65.4% of the cases were subjects with childhood-onset asthma. In contrast, we recruited subjects with adult asthma, though 19.6% of the cases in the GWAS were subjects with childhood-onset asthma. Asthma has various clinical phenotypes that show age-related variation. The heterogeneity of phenotypes between these studies might have influenced these results. The peak of association at 6p21 in this study was located close to rs2070600, which was associated with FEV 1 /FVC in GWAS of lung function in healthy individuals 12, 13 . We found for the first time, to our knowledge, an association of asthma with the TSLP-WDR36 locus at a genome-wide significant level. A SNP in the TSLP-WDR36 locus was associated with adult asthma in populations of both Japanese and non-Hispanic individuals of European ancestry. Further studies are necessary for better understanding of the clear role of genetic etiology and the pathophysiology of bronchial asthma.
URLs. The Leading Project for Personalized Medicine, http:// biobankjp.org/; Haploview v4.2, http://www.broadinstitute.org/ scientific-community/science/programs/medical-and-populationgenetics/haploview/haploview; PLINK statistical software v1.06, http://pngu.mgh.harvard.edu/~purcell/plink/; llumina's IconDB resource, http://www.illumina.com/science/icontroldb.ilmn.
METhOdS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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